Molecular Diagnostics
Early Stage Cancer CTCs Indicators of Poor Prognosis
By testing blood from a pulmonary vein near the site of a lung tumor rather than from a peripheral vein, cancer researchers found that the presence of circulating tumor cells (CTCs) in the blood during early stages of the disease was indicative of a poor prognosis for the patient. More...12 Sep 2017
Antibacterial Resistance Revealed in Women with UTIs
Nearly 20% of women aged 15-29 are diagnosed with a urinary tract infection (UTI) and antibiotic resistance prolongs UTI treatment and resistance profiles vary regionally. This regional variation is an important consideration in guiding empirical treatment selection. More...08 Sep 2017
Blood Test Predicts Prostate Tumor Resistance
Prostate cancer (PCa) is the most common cancer and the third leading cause of cancer death among European men. In metastatic PCa progression from a hormone-sensitive state to castration resistance under androgen deprivation therapy marks the transition to the lethal phenotype of the disease. More...07 Sep 2017
Novel PCR Test Detects H. Pylori Drug Resistance
An estimated one million new cases of gastric cancer and 720,000 gastric cancer related deaths occur worldwide each year. Helicobacter pylori is a Group 1 carcinogen that is responsible for approximately 89% of lower stomach gastric cancer cases. More...06 Sep 2017
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Immunofluorescence Analyzer
IFA System
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
In Other News
Molecular Blood Test Could Identify Alzheimer's
New Assay Facilitates Diagnosis of Rare Infant Disease
Disposable POC Device Introduced for Low-Resource Areas
Test Detects Cancer Mutations from Circulating DNA
Molecular Blood Test Developed for Kidney Cancer
Gene Expression Profiling Validated for Uveal Melanoma
Deep Sequencing of Circulating Tumor DNA Detects Cancers Early
Bone Peptide Measurement Predicts Fracture Risk
DNA Sequencing of MRSA Predicts Patient Survival
New Molecular Test Identifies Colorectal Cancer
CRISPR Technology Identifies Cancer-Causing Genes
Liquid Biopsy Approach Inspired by Swarm Behavior
Biosensor Device Developed for Zika Diagnosis
Cytokine Concentration Linked to Chronic Fatigue Syndrome
Mutations Related to Hereditary Neuroendocrine Tumors
Blood Test Detects Brain Metastases While Treatable
Neurological Disease Traced to Gene Error
Smartphone-Based ELISA Developed for Blood Antigens
Dried Blood Assessment Equivalent to Drawn Blood Samples
Test Discriminates Between Viral and Bacterial Infections
CRISPR Illuminates Pediatric Bone Marrow Failure Syndrome
Five Vascular Diseases Linked to One Genetic Variant
Liquid Biopsy Could Identify Advanced Breast Cancer Patients
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
